Keyphrases
Antithrombin III (ATIII)
100%
Arixtra
100%
Gas-phase Conformation
100%
Traveling Wave Ion Mobility Spectrometry (TWIMS)
100%
Heparin
15%
Collision Cross Section
15%
Conformational Change
10%
Protein Conformational Change
10%
Mobility Behavior
10%
Glycosaminoglycan Ligands
10%
Well-defined
5%
Binding Affinity
5%
Biological Activity
5%
Heparin Oligosaccharides
5%
Inhibition Rate
5%
Sulfo Group
5%
Tetrasaccharide
5%
Glucosamine
5%
Pentasaccharide
5%
Tertiary Structure
5%
Non-specific Binding
5%
Solution Structure
5%
Serine Protease Inhibitor
5%
Collisional Activation
5%
Coagulation Cascade
5%
Pharmaceutical Agents
5%
Ion Mobility
5%
Interaction Mode
5%
Protein-carbohydrate Complex
5%
Equilibrium Constant
5%
Anticoagulant Drugs
5%
Single Structure
5%
Nondenaturing Conditions
5%
3-O-sulfation
5%
Native Electrospray Ionization Mass Spectrometry
5%
Protein Crystal Structure
5%
Binding Behavior
5%
Promiscuous Interaction
5%
Native Topology
5%
Synthetic Heparin
5%
Theoretical Estimation
5%
Biochemistry, Genetics and Molecular Biology
Conformation
100%
Antithrombin
100%
Ion-Mobility Spectrometry
100%
Heparin
25%
Conformational Change
20%
Glycosaminoglycan
10%
Solution and Solubility
5%
Coagulation System
5%
Biological Activity
5%
Binding Affinity
5%
Oligosaccharide
5%
Tertiary Structure
5%
Sulfation
5%
Serine Protease Inhibitor
5%
Tetrasaccharide
5%
Ion Mobility Mass Spectrometry
5%
Electrospray Mass Spectrometry
5%
Equilibrium Constant
5%
Protein Crystal Structure
5%
Glucosamine
5%
Immunology and Microbiology
Conformation
100%
Conformational Transition
100%
Crystal Structure
25%
Biological Activity
25%
Binding Affinity
25%
Blood Clotting
25%
Sulfation
25%
Ion Mobility Mass Spectrometry
25%
Electrospray Mass Spectrometry
25%
Solution Structure
25%
Equilibrium Constant
25%
Chemistry
Antithrombin
100%
Ion Mobility Spectroscopy
100%
Heparin
20%
Collisional
15%
Glycosaminoglycan
10%
Kd
5%
Crystal Structure
5%
Sulfo Group
5%
Oligosaccharide
5%
Pentasaccharide
5%
Serine Protease Inhibitor
5%
Anticoagulant Agent
5%
Collisional Activation
5%
Bioactivity
5%
Electrospray Ionization Mass Spectrometry
5%
Equilibrium Constant
5%
Tertiary Structure
5%
Ion Mobility
5%
Ion Mobility Mass Spectrometry
5%
Heparin Tetrasaccharide
5%
stability
5%
sulfation
5%
solution structure
5%
Glucosamine
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antithrombin III
100%
Fondaparinux
100%
Heparin
25%
Glycosaminoglycan
10%
Anticoagulant Agent
5%
Biological Activity
5%
Glucosamine
5%
Pentasaccharide
5%
Oligosaccharide
5%
Serine Proteinase Inhibitor
5%
Electrospray Ionization
5%
Tetrasaccharide
5%